Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sabat

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Zeitschrift Fur Rheumatologie|October 28, 2003
[Use of biologicals in psoriasis]M Friedrich, S Philipp, R Sabat, et al.
Molecular Immunology|October 1, 1996
Neutralizing murine monoclonal anti-interleukin-10 antibodies enhance binding of antibodies against a different epitopeR Sabat, M Seifert, H D Volk, et al.
Trends in Immunology|August 29, 2001
IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targetsH Volk, K Asadullah, G Gallagher, et al.
Genes and Immunity|May 6, 2005
The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytesK Wolk, G Grütz, K Witte, et al.
Clinical and Experimental Immunology|December 18, 2003
Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50F Driessler, K Venstrom, R Sabat, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2000
Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysisK Wolk, W Döcke, V von Baehr, et al.
Free Radical Biology & Medicine|May 23, 2001
Immunological dysregulation of lung cells in response to vitamin E deficiencyR Sabat, I Kolleck, W Witt, et al.
Blood|July 13, 2000
Impaired antigen presentation by human monocytes during endotoxin toleranceK Wolk, W D Döcke, V von Baehr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 3, 2018
[Correction to: Drug therapy of acne inversa]S Schneider-Burrus, E Arpa, C Kors, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
Immunomodulatory therapies: challenges of individualized therapy strategiesH D Volk, B Sawitzki, F Kern, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Zeitschrift Fur Rheumatologie|October 28, 2003
[Use of biologicals in psoriasis]M Friedrich, S Philipp, R Sabat, et al.
Molecular Immunology|October 1, 1996
Neutralizing murine monoclonal anti-interleukin-10 antibodies enhance binding of antibodies against a different epitopeR Sabat, M Seifert, H D Volk, et al.
Trends in Immunology|August 29, 2001
IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targetsH Volk, K Asadullah, G Gallagher, et al.
Genes and Immunity|May 6, 2005
The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytesK Wolk, G Grütz, K Witte, et al.
Clinical and Experimental Immunology|December 18, 2003
Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50F Driessler, K Venstrom, R Sabat, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2000
Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysisK Wolk, W Döcke, V von Baehr, et al.
Free Radical Biology & Medicine|May 23, 2001
Immunological dysregulation of lung cells in response to vitamin E deficiencyR Sabat, I Kolleck, W Witt, et al.
Blood|July 13, 2000
Impaired antigen presentation by human monocytes during endotoxin toleranceK Wolk, W D Döcke, V von Baehr, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 3, 2018
[Correction to: Drug therapy of acne inversa]S Schneider-Burrus, E Arpa, C Kors, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
Immunomodulatory therapies: challenges of individualized therapy strategiesH D Volk, B Sawitzki, F Kern, et al.
Pageof 7